December 20, 2014 7:29 PM ET

Capital Markets

Company Overview of Actis Capital, LLP

Company Overview

Actis Capital, LLP is a private equity and venture capital firm specializing in expansion capital, PIPEs, replacement capital, acquisitions, industry consolidation, management buyouts/buyins, leveraged buyouts, going private transactions, privatizations, property development finance, and mezzanine finance investments in emerging and growing companies. It does not invest in seed and startup stage; and military and gambling. The firm primarily seeks to invest in companies operating in consumer including education, food and beverage, home and personal care, restaurants and retail; financial services including banking, consumer credit, financial services distribution and payments; healthcare inc...

2 More London Riverside

London,  SE1 2JT

United Kingdom

Founded in 2004

Phone:

44 20 7234 5000

Fax:

44 20 7234 5010

Key Executives for Actis Capital, LLP

Chief Executive Officer
Director and Head of Operations
Chief Investment Officer
Partner and General Counsel
Partner and Co-Head of Energy
Compensation as of Fiscal Year 2014.

Actis Capital, LLP Key Developments

Carlyle Reportedly Set To Acquire Destimoney From NSR

The Carlyle Group LP (NasdaqGS:CG) has come up as a frontrunner in race to acquire Destimoney Enterprises Private Limited from New Silk Route (NSR). According to the sources, the potential transaction is valued at INR 12 billion. The news report mentioned that formal announcement is due in the coming weeks. An official added, “Carlyle will most certainly buyout NSR from the housing finance JV. Last moment discussions are still on for the residual businesses like broking, distribution and I banking, which are much smaller in scale and size.” The news report mentioned that NSR and Carlyle's spokespersons declined to comment on the matter. Since 2013, NSR has been trying to monetize Destimoney investment and has had discussions with firms like General Atlantic LLC, Actis Capital, LLP, ChrysCapital and GIC Pte. Ltd. However, talks with most fell through.

ChrysCapital Reportedly In Talks To Sell Mankind Pharma

ChrysCapital intends to sell its stake in Mankind Pharma Limited. ChrysCapital is holding talks to sell its 11% stake in Mankind Pharma. The potential buyers are all PE firms, including Temasek Holdings (Private) Limited, General Atlantic LLC, Actis Capital, LLP and Advent International Corporation. ChrysCapital hopes to fetch over $200 million for its 11% holding. Financial Services Monitor Worldwide added that Ramesh Juneja, Chief Executive Officer of Mankind, said in an email response: Regarding ChrysCapital seeking exit from Mankind you may directly speak with them because it is entirely their decision. ChrysCapital spokesperson Sanjiv Kaul declined comment.

Chryscapital-GIC Team Emerges As Front-Runner In Race To Buy Destimoney

A consortium of ChrysCapital and GIC Pte. Ltd. has emerged as the front-runner to purchase New Silk Route's (NSR) 100% stake in Destimoney Enterprises Private Limited. "They seem to have gained a clear edge over rival bidders", said a person directly involved with the transaction. The deal may value the company between INR 10 billion and INR 11 billion. NSR has mandated Morgan Stanley to sell Destimoney. Actis Capital, LLP and General Atlantic LLC had also participated in the bidding. While New Silk Route's Chief Executive Officer Parag Saxena did not reply to email questions on the subject, Destimoney's Managing Director and Chief Executive Officer Sudip Bandyopadhay declined comment.

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 15, 2014
Al Borg Laboratories
Private Placement
December 5, 2014
Université Centrale Group
Merger/Acquisition
November 20, 2014
The Nilgiri Dairy Farm Private Limited
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Actis Capital, LLP, please visit www.act.is. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.